File(s) not publicly available
PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL
conference contribution
posted on 2020-11-01, 00:00 authored by Eric Thompson, Daniel Landi, Eric Lipp, Bea Balajonda, James Herndon, Evan Buckley, Charlene Flahiff, Denise Jaggers, Kristin Schroeder, Dina Randazzo, Annick Desjardins, Maggie Johnson, Katherine Peters, Mustafa KhasrawMustafa Khasraw, Michael Malinzak, Duane Mitchell, David Ashley, John SampsonPEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL